Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
|
Results for 'Commercial Insight: Epilepsy' |
|
|
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Pipeline Insight: Epilepsy Past successes hard to emulate in highly genericized market |
May 2010 | £7,210 | 100% |
| Pipeline Insight: Epilepsy Pipeline drugs struggle to outshine their marketed predecessors |
Oct 2006 | £7,210 | 97% |
| Anticonvulsants Market to 2016 Cost Advantage and Dosage Convenience Provided by Generic Anticonvulsants Will Limit Commercial Opportunities for Novel Therapies |
Jan 2011 | £2,215 | 96% |
| Advances in Neurostimulators | Apr 2010 | £4,110 | 83% |
| Neuromodulation Devices: World Market Prospects 2011-2021 |
Oct 2011 | £1,699 | 75% |
| Stakeholder Opinions: Diagnostics in Neurology Predictive Biomarkers Expand Drug Revenues |
Jul 2008 | £2,400 | 74% |
| Commercializing Biomarkers in Therapeutic and Diagnostic Applications | May 2011 | £2,020 | 62% |
| New Drug Futures 2009 | Jan 2012 | £1,995 | 57% |
| Cytogenetics Technologies, Markets and Companies |
Jan 2012 | £1,620 | 50% |
| Nuclear Medicine | Oct 2010 | £2,845 | 45% |
| Molecular Diagnostics | Oct 2010 | £2,845 | 39% |
| United States Diagnostic Imaging Market Outlook to 2017 Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others |
Sep 2011 | £1,580 | 36% |
- Results 1 - 12 of 12
-
-
- 1
-
-
